Terveen        Page

Daniel C. Terveen, MD

3101 W 57th St. Sioux Falls, SD, 57108 | 5003 S. Bur Oak Pl. Sioux Falls SD 57108

605-645-7999

Daniel.terveen@vancethompsonvision.com

Professional Employment

Vance Thompson Vision, Sioux Falls, SD

Specialist in Glaucoma, Cornea, External Disease and Refractive Surgery         2020-present

University of South Dakota-Sanford School of Medicine, Sioux Falls, SD

Associate Clinical Professor - Surgery         2020-present

Interfeen Biologics Inc, Sioux Falls, SD

Founder and CEO         2022-present

Balance Ophthalmics Inc, Sioux Falls, SD

Board Observer        2023-present

True North Contract Research, Sioux Falls, SD

Board Member and Founding Member        2023-present

GreenMan Vision Inc, Fargo, ND

Strategic Advisor, Board Member         2023-present

EDUCATION

Vance Thompson Vision, Sioux Falls, SD

Fellowship in Cornea, External Disease and Refractive Surgery         2019-2020

University of Iowa Hospitals and Clinics, Iowa City, IA

Resident in Ophthalmology        2016-2019

University of Iowa Hospitals and Clinics, Iowa City, IA

Integrated Internship in Internal Medicine/Ophthalmology        2015-2016

University of South Dakota-Sanford School of Medicine, Vermillion, SD

Doctor of Medicine         2011-2015

Summa Cum Laude, Scholarship Pathway in Research

University of Sioux Falls, Sioux Falls, SD

B.S. in Biology and B.S. in Chemistry        2007-2011

Magna Cum Laude

Institute for Healthcare Improvement Open School

Certificate of Completion        2014

LEADERSHIP ACTIVITIES

AAO Leadership Development Program        2023-Present

Class of 2024

AAO Council        2022-Present

Councilor for South Dakota

ASCRS Government Relations Committee        2022-Present

RUC Representative

AAO State Affairs Committee        2022-2023

Regional Representative (SD,ND,MN,MT)

AAO Young Ophthalmologist Advocacy Committee        2019-2022

Committee Member

University of Iowa House Staff Council

House Staff Council President        2018-2019

American Medical Association

Alternate Delegate, RFS Standing Committee on Legislation        2017-2019

American Academy of Ophthalmology

Advocacy Ambassador        2017-2019

University of Iowa House Staff Council

Ophthalmology Representative        2017-2019

Iowa Medical Society-Johnson County Medical Society Division

President-elect(2017), President(2018)        2017-2019

University of Iowa Quality and Safety Oversight Committee

Resident Representative        2017-2019

University of Iowa Graduate Medical Education Committee

Resident Representative        2017-2019

University of Iowa Eyerounds

Editorial Board Member        2016-2019

University of Iowa Ophthalmology Program Evaluation Committee

Resident Representative        2016-2019

South Dakota Medical Society

Medical Student Representative        2014-2015

Internal Medicine Interest Group (IMIG)

Chair        2012-2015

South Dakota Student Council for Public Health

Chair        2012-2015

American College of Physicians

South Dakota ACP Student Representative        2011-2015

USD Medical School Student Liaison

Liaison        2013-2015

University of Sioux Falls

Student Body President and Trustee        2010-2011

Coo Tycoons Investment Club

Vice-President & Director of Strategic Planning        2010-2011

University of Sioux Falls

Varsity Tennis        2007-2011

VOLUNTEER ACTIVITIES

     University of Iowa Free Clinic

     Ophthalmology Volunteer        2016-2019

South Dakota AOA Mentors Program

Mentor        2013-2015

Feeding South Dakota

Volunteer and Outreach Director        2013-2015

Northern Plains Eye Foundation

Volunteer and Research Coordinator        2013-2015

Good Shepherd Clinic

Volunteer at free clinic        2013-2015

RESEARCH EMPLOYMENT HISTORY

Children’s Vision Screening Initiative

Research Coordinator        2013-2017

Scholarship Pathways

Research tract in medical school        2011-2015

South Dakota Biomedical Research Infrastructure Network

Research Associate        2009-2011

AWARDS and honors

USF Alumni Pacesetter Award         2023

Lisa Arbisser Top Gun Resident Award         2019

PJ Leinfelder Resident Research Award         2019

ASCRS Council of 100 Leadership Committee         2016

ASCRS Best Paper of Session (also Hot of the Press)         2015

Deans’ Academic Achievement Award (Given to the top student in medical class)         2015

AOA Honors Society         2014

Pathology Honors (Given to the top student)         2013

Ron Trautman Medical Student Scholarship (Competitive Scholarship)         2013

Faithe Family Scholarship (Competitive Scholarship)         2012

University of Sioux Falls Representative Student Award         2011

University of Sioux Falls Honors Scholar         2007–2011

All-American Scholar Athlete (Tennis)         2009 & 2010

Alpha Chi National College Honor Society         2009

research Presentations

“Outcomes of Superonasal vs. Inferonasal Ab Interno Collagen Gel Stent Placement in Patients with Refractory Glaucoma”

Presentation at the ASCRS Annual Meeting         April 2022

“Long-Term Efficacy of Canaloplasty and Trabeculotomy in Pseudophakic Eyes with Open-Angle Glaucoma”

Presentation at the ASCRS Annual Meeting         April 2022

“Effectiveness of Intracameral Bimatoprost Implant Combined with Selective Laser Trabeculoplasty in Lowering IOP”

Presentation at the ASCRS Annual Meeting         April 2022

“Real World Experience and Outcomes with Sustained Release Bimatoprost Implant”

Presentation at the ASCRS Annual Meeting         April 2022

“Patient Satisfaction of a Trifocal IOL in Patients with Previous Myopic Refractive Surgery”

Presentation at the ASCRS Annual Meeting         April 2022

“Refractive Outcomes of Trifocal IOL in Patients with Previous Myopic Refractive Surgery”

Presentation at the ASCRS Annual Meeting         April 2022

“Real World Experience and Outcomes with Sustained Release Bimatoprost Implant”

Presentation at the ASCRS Annual Meeting         July 2021

“Post-Cataract Laser Enhancement in Patients with Small Refractive Error”

Presentation at the ASCRS Annual Meeting         July 2021

“Post-Cataract LASIK Versus PRK Enhancement Outcomes”

Presentation at the ASCRS Annual Meeting         July 2021

“Post-Cataract Enhancements in Patients with Prior Refractive Surgery”

Presentation at the ASCRS Annual Meeting         July 2021

“Corneal Cross-Linking Outcomes in Patients with Thin Corneas”

Presentation at the ASCRS Annual Meeting         July 2021

“Efficacy of Ab Interno Canaloplasty Followed By Trabeculotomy in Pseudophakic Eyes with Open-Angle Glaucoma”

Presentation at the ASCRS Annual Meeting         July 2021

Retrospective Analysis of the AAO Clinical Registry to Correlate IOL Type and Biomaterial to Time to PCO Diagnosis

Presentation at the AAO Annual Meeting         November 2020

Real-World Characteristics of Patients Undergoing Cataract Surgery: Analysis of U.S. Medicare Claims Database

Presentation at the AAO Annual Meeting         November 2020

“The Impact of Topical Glycerin on DMEK Graft Adherence”

Presentation at the ASCRS Annual Meeting         May 2020

“Real World IOL Usage in Cataract Patients with Hydrophobic Acrylic IOL Implantation from AAO IRIS Registry

Poster at the ASCRS Annual Meeting         May 2020

“Impact of Elimination of Preoperative Fasting Requirements for Cataract Surgery Patients

Presentation at the ASCRS Annual Meeting         May 2020

“Ocular Surface Flora Changes Prior to Cataract Surgery with and without Use of Pre-Operative Topical Moxifloxacin

Presentation at the ASCRS Annual Meeting         May 2020

“Description of a Retrospective Study Using EHR Based Registry to Correlate IOL Biocompatibility with YAG”

Poster at the AAO Annual Meeting         October 2019

Description of EHR-Based Registry Study to Correlate Toric IOL Biomechanics With Repositioning Incidence

Poster at the AAO Annual Meeting         October 2019

“Resident experience and learning curve with iStent”

Presentation at the ASCRS Annual Meeting         May 2019

 “Intravenous line usage in patients undergoing resident performed cataract surgery at the VA Medical Center”

Presentation at the ASCRS Annual Meeting         May 2019

“Effect of intracameral mydriatics on intraoperative floppy iris syndrome (IFIS) at the VA Medical Center”

Presentation at the ASCRS Annual Meeting         May 2019

“Outcomes and cost savings of resident performed immediately sequential bilateral cataract surgery (ISBCS)”

Presentation at the AAO Annual Meeting         October 2018

“Accuracy of partial coherence interferometry in patients with large inter-eye axial length difference”

      Presentation at the AAO Annual Meeting         October 2018

“Astigmatic outcomes of descemet membrane endothelial keratoplasty (DMEK) at a tertiary referral center”

Presentation at the AAO Annual Meeting         October 2018

The Impact of Recipient Diabetes Mellitus Status on DMEK Outcomes

Presentation at the AAO Annual Meeting         October 2018

“Intracameral moxifloxacin for endophthalmitis prophylaxis at the VA Medical Center”

Podium Presentation at the ASCRS Annual Meeting         April 2018

“Four-point scleral fixation of a PC-IOL combined with partial thickness corneal transplant”

Podium Presentation at the ASCRS Annual Meeting         May 2016

“Four-point scleral fixation of a hydrophilic, acrylic posterior chamber intraocular lens”

Podium Presentation at the ASCRS Annual Meeting         April 2015

“The impact of insurance status on hospital charges for pediatric ophthalmic inpatients”

Poster presentation at the AAPOS National Meeting        March 2014

“Feeding South Dakota: Packing backpacks to feed our youth”

Poster presentation at the Cultural Colloquium Student Poster Presentation        December 2013

“The impact of insurance status on hospital charges for pediatric cardiovascular inpatients”

Poster at the Pediatric Academic Societies national meeting in Washington, DC        May 2013

“Malaria in the Black Hills: Pathogen mediated selection of MHC alleles in the White-winged Junco”

Presented at the Biomedical Research Infrastructure Network Convocation        Fall 2010

Malarial parasites in the White-winged Junco: the impacts of seasonality, sex, and body condition on infection rates

Presented at the state capitol for an Undergraduate Research Day        Spring 2010

Peer Reviewed Publications 

Nieuwsma A, Vander Zee BL, Berdahl JP, Ibach M, Ferguson TJ, Terveen D. Evaluating the safety and efficacy of epi-off corneal cross-linking in patients with thin corneas due to keratectasia. Ther Adv Ophthalmol. 2023 Sep 15;15:25158414231197064. doi: 10.1177/25158414231197064. PMID: 37720204; PMCID: PMC10504847.

Ferguson TJ, Wilson CW, Shafer BM, Berdahl JP, Terveen DC. Clinical Outcomes of a Non-Diffractive Extended Depth-of-Focus IOL in Eyes with Mild Glaucoma. Clin Ophthalmol. 2023 Mar 15;17:861-868. doi: 10.2147/OPTH.S404369. PMID: 36945324; PMCID: PMC10024873.

Terveen DC, Sarkisian SR Jr, Vold SD, Selvadurai D, Williamson BK, Ristvedt DG, Bleeker AR, Dhamdhere K, Dickerson JE Jr. Canaloplasty and trabeculotomy with the OMNI® surgical system in OAG with prior trabecular microbypass stenting. Int Ophthalmol. 2023 May;43(5):1647-1656. doi: 10.1007/s10792-022-02553-6. Epub 2022 Oct 13. PMID: 36229561; PMCID: PMC10149460.

Murphy Iii JT, Terveen DC, Aminlari AE, Dhamdhere K, Dickerson JE Jr; ROMEO Study Group. A Multicenter 12-Month Retrospective Evaluation of Canaloplasty and Trabeculotomy in Patients with Open-Angle Glaucoma: The ROMEO 2 Study. Clin Ophthalmol. 2022 Sep 14;16:3043-3052. doi: 10.2147/OPTH.S384105. Erratum in: Clin Ophthalmol. 2022 Sep 22;16:3107-3108. PMID: 36128338; PMCID: PMC9482782.

Rohlf D, La Nasa A, Terveen D, Shafer B, Thompson V, Berdahl J. Outcomes of LASIK vs PRK enhancement in eyes with prior cataract surgery. J Cataract Refract Surg. 2023 Jan 1;49(1):62-68. doi: 10.1097/j.jcrs.0000000000001028. PMID: 36026691.

Bleeker AR, Litchfield WR, Ibach MJ, Greenwood MD, Ristvedt D, Berdahl JP, Terveen DC. Short-Term Efficacy of Combined ab Interno Canaloplasty and Trabeculotomy in Pseudophakic Eyes with Open-Angle Glaucoma. Clin Ophthalmol. 2022;16:2295-2303. doi: 10.2147/OPTH.S367896.

Horn JD, Fisher BL, Terveen D, Fevrier H, Merchea M, Gu X. Academy IRIS® Registry Analysis of Incidence of Laser Capsulotomy Due to Posterior Capsule Opacification After Intraocular Lens Implantation. Clin Ophthalmol. 2022;16:1721-1730. doi: 10.2147/OPTH.S358059. eCollection 2022. PubMed PMID: 35673348; PubMed Central PMCID: PMC9167596.

Terveen D, Berdahl J, Dhariwal M, Meng Q. Real-World Cataract Surgery Complications and Secondary Interventions Incidence Rates: An Analysis of US Medicare Claims Database. J Ophthalmol. 2022;2022:8653476. doi: 10.1155/2022/8653476. eCollection 2022. PubMed PMID: 35433042; PubMed Central PMCID: PMC9007656.

Wirta D, Vollmer P, Paauw J, Chiu KH, Henry E, Striffler K, Nau J. Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The ONSET-2 Phase 3 Randomized Trial. Ophthalmology. 2022 Apr;129(4):379-387. doi: 10.1016/j.ophtha.2021.11.004. Epub 2021 Nov 10. PubMed PMID: 34767866.

Hock LE, Kennedy S, Wilson CW, Polking A, Portwood J, Oetting T, Terveen D. Oral anxiolytics prior to routine resident cataract surgery eliminate need for intravenous sedation at a Veterans Affairs Hospital. Am J Ophthalmol Case Rep. 2022 Mar;25:101379. doi: 10.1016/j.ajoc.2022.101379. eCollection 2022 Mar. PubMed PMID: 35198808; PubMed Central PMCID: PMC8842029.

Eisenbeisz HC, Bleeker AR, Terveen DC, Berdahl JP. Descemet Membrane Endothelial Keratoplasty and light adjustable lens triple procedure. Am J Ophthalmol Case Rep. 2021 Jun;22:101061. doi: 10.1016/j.ajoc.2021.101061. eCollection 2021 Jun. PubMed PMID: 33718662; PubMed Central PMCID: PMC7933706.

Petersen CA, Terveen DC, Quist T, Taravati P, Ding L, Oetting TA, Chen PP. Accuracy of partial coherence interferometry in patients with large inter-eye axial length difference. PLoS One. 2021;16(2):e0246721. doi: 10.1371/journal.pone.0246721. eCollection 2021. PubMed PMID: 33561129; PubMed Central PMCID: PMC7872294.

Wilson CW, Hock LE, Oetting T, Kennedy S, Terveen D. Pupil expansion device use and operative outcomes with topical dilation vs intracameral epinephrine in resident-performed cataract surgery. J Cataract Refract Surg. 2020 Apr;46(4):562-566. doi: 10.1097/j.jcrs.0000000000000106. PubMed PMID: 32271295.

Janson BJ, Terveen DC, Benage MJ, Zimmerman MB, Mixon DC, Aldrich BT, Skeie JM, Schmidt GA, Reed CR, Goins KM, Greiner MA. DMEK outcomes using nondiabetic grafts for recipients with diabetes mellitus. Am J Ophthalmol Case Rep. 2019 Sep;15:100512. doi: 10.1016/j.ajoc.2019.100512. eCollection 2019 Sep. PubMed PMID: 31341996; PubMed Central PMCID: PMC6630035.

Terveen DC, Zhang Z, Alward WLM. Heritable Optic Nerve Asymmetry in Monozygotic Twins. Ophthalmol Glaucoma. 2018 Sep - Oct;1(2):144. doi: 10.1016/j.ogla.2018.07.002. Epub 2018 Oct 12. PubMed PMID: 32672564.

Terveen DC, Fram NR, Ayres B, Berdahl JP. Small-incision 4-point scleral suture fixation of a foldable hydrophilic acrylic intraocular lens in the absence of capsule support. J Cataract Refract Surg. 2016 Feb;42(2):211-6. doi: 10.1016/j.jcrs.2015.10.068. PubMed PMID: 27026444.

Terveen DC, Moser JM, Spencer TS. Results of a pediatric vision screening program in western South Dakota. S D Med. 2015 Mar;68(3):111-3, 115. PubMed PMID: 25906499.

Book ChapterS

Terveen DC, et al. “Chapter 49”, Curbside Consultation in Cornea and External Diseases, Second Edition by Hardten and Hansen. Slack Inc. 2021 pp. 269-272.

Terveen DC, Berdahl JP. Book Chapter: “Scleral Sutured PC-IOL in eyes lacking capsular support.” Agarwal A. More Phaco Nightmares: Conquering Cataract Catastrophes. Thorofare, NJ: Slack Incorporated; 2018.

Thompson V., Terveen DC. LASIK and PRK Patient Evaluation and Selection. In: Albert D., Miller J., Azar D., Young L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer. 2021

Moser J., Mehrotra P, Terveen,DC, Bergeon-Burns C, Ketterson E, & Spellman G. 2010. Malarial Parasite Infection and MHC Variability in the White Winged Junco. Published by the South Dakota Academy of Science, 89, 290.

PROFESSIONAL MEMBERSHIPS

South Dakota Medical Society, South Dakota Academy of Ophthalmology, American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, American Medical Association

CLINICAL TRIALS as PRINCIPAL INVESTIGATOR

  1. The ONSET-2 Study-A Phase 3, Multicenter, Randomized, Controlled, Double-Masked, Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease
  1. Sponsor: Oyster Point Pharma, Inc
  1. Ophthalmic Assessments of Signs and Symptoms of Dry Eye in Patients Suffering from Self-Reported or Clinician-Diagnosed Dry Eye Disease
  1. Sponsor: Ora
  1. EQX CP-019 The Artemis Study- Negative Pressure Applied by the Equinox Mercury™ Multi-Pressure Dial as an Adjunct Therapy for Lowering Intraocular Pressure in Subjects with Normal Tension Glaucoma
  1. Sponsor: Equinox Ophthalmic, Inc
  1. EQX CP-020 A Prospective Study to Evaluate the Ability to Determine Intracranial Pressure by Modulation Intraocular Pressure Using Negative Pressure Applied to the Periocular Microenvironment Anterior to the Orbital Rim
  1. Sponsor: Equinox Ophthalmic, Inc
  1. EQX CP-022 The Ranger Study- Negative Pressure Applied by the Equinox Mercure Multi-Pressure Dial to Lower and Modulate Intraocular Pressure in Subjects with Severe Open Angle Glaucoma
  1. Sponsor: Equinox Ophthalmic, Inc
  1. Vivity in Glaucoma IIT
  1. Sponsor: Vance Thompson Vision
  1. Crosslinking in less than 400microns IIT
  1.  Sponsor: Vance Thompson Vision
  1. TEAR-2020-401-A Prospective, Observational, Consecutive, Qualitative, Multicenter Study Assessing Eye Drop Administration
  1. Sponsor: Ocular Therapeutix, Inc
  1. CBT-CS301  A Multicenter, Double-Masked, Randomized, Vehicle-Controlled 12-Month (with a

12-month, Double-Masked Extension) Parallel Comparison of the Safety and Efficacy

of 0.1% and 0.2% CBT-001 versus Vehicle, Dosed Twice-Daily, in Patients with

Pterygium

  1. Sponsor: Cloudbreak Therapeutics LLC
  1. SBL-3-PAS-001  Lenstec SBL-3 Intraocular Lens Post Approval Study
  1. Sponsor: Lenstec, Inc.
  1. Comparison of visual acuity and visual quality of life outcomes following Contoura with Phorcides compared to WaveLight Wavefront optimized LASIK IIT
  1. Sponsor: Vance Thompson Vision, Prof LLC

CLINICAL TRIALS as a SUB-NVESTIGATOR

  1. A Randomized, Masked (Reading Center), Controlled, Prospective Pivotal Study of the Effectiveness and Safety of the EyeGate Ocular Bandage Gel, a 0.75% Crosslinked Hyaluronic Acid Applied Topically, Versus A Bandage Contact Lens in Accelerating Re-Epithelialization of Large Corneal Epithelial Defects in Patients Having Undergone Photorefractive Keratectomy (PRK)
  1. Sponsor: EyeGate Pharmaceuticals, Inc.
  1. BRAVO-Clinical Investigation of the Safety and Effectiveness of an Investigational Model of the TECNIS Intraocular Lens SUR-CAT-652-2001
  1. Sponsor: Johnson & Johnson Surgical Vision, Inc.
  1. LAL CSP-027-A Prospective Randomized Controlled Multi-Center Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects with Prior Corneal Refractive Surgery
  1. Sponsor: RxSight, Inc.
  1. LAL CSP-034-A Prospective Controlled Multi-Center Clinical Study to Evaluate the Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available Light Adjustable Lens
  1. Sponsor: RxSight, Inc.
  1. A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension
  1. Sponsor: Allergan
  1. MEL90-A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the MEL 90 Excimer Laser using LASIK (Laser IN SITU Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism
  1. Sponsor: Carl Zeis
  1. STAAR EVO-A Multicenter Clinical Evaluation of the EVO/EVO+ Visian®  Implantable Collamer® Lens
  1. Sponsor: STAAR Surgical Company
  1. B&L 884 TENEO-A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism (B&L 884)
  1. Sponsor: Bausch and Lomb Incorporated
  1. J&J MONO-Post-approval Study of Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects with Presbyopia
  1. Sponsor: Johnson & Johnson Surgical Vision, Inc
  1. AR-13324-CS210-A Randomized, Open-Label, Parallel-Group Study to Evaluate the Safety and efficacy of Two Dosing Regimens of Netarsudil Ophthalmic Solution in Patients with Corneal Edema Due to Fuchs Corneal Dystrophy.
  1. Sponsor: Aerie Pharmaceuticals, Inc
  1. Long Term Outcomes of Vivity IOL versus Control (Alcon-Revive) IIT
  1. Sponsor: Vance Thompson Vision
  1. A randomized, double-masked, multicenter study to evaluate the safety and efficacy of ECF843 vs Vehicle in subjects with dry eye disease.  
  1. Sponsor: Novartis                                                                                                                                                
  1. TTHX-001-A Phase 1/Phase 2 Study Evaluating the Safety and Efficacy of the Investigational New Drug TTHX1114(NM141) on the Regeneration of Corneal Endothelial Cells in Patients with Corneal Endothelial Dystrophies following Intracameral Delivery.  (TTHX-001)
  1.  Sposnor: TreFoil Therapeutics
  1. LAL CSP-033-A Prospective Randomized Controlled Multi-Center Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects Desiring an Extended Depth of Focus                  
  1. Sponsor: Rx Sight
  1. Alcon Lasik RFP911-C001-Pivotal Trial of WaveLight EX500 Excimer Laser System for the Correction of Myopia with and without Astigmatism using InnovEyes in Conjunction with InnovEyes sightmap                            
  1. Sponsor: Alcon
  1. IG2M-105-PASN- iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study
  1. Sponsor: Glaukos
  1. IDOS-106-EXCH- Prospective, non-randomized, open label, multi-center, single arm study of exchange of

travoprost intraocular implant

  1. Sponsor: Glaukos
  1. SAHARA-Prospective, Randomized, Masked, Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare System in the Treatment of the Signs and Symptoms of DryEye Disease
  1. Sponsor: Sight Sciences
  1. TTHX-002-Phase 2 Study To Determine the Safety and Efficacy of the Investigational New Drug TTHX1114(NM141) on the Regeneration and Migration of Corneal Endothelial Cells in Patients undergoing Descemetorhexis without Endothelial Keratoplasty (Descemet Stripping Only)
  1. Sponsor: TreFoil Therapeutics
  1. B&L 945 EnVista -A Prospective, Multicenter, Randomized, Active-Controlled Clinical Study to Evaluate the Safety and Effectiveness of the enVista One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction.
  1. Sponsor: Bausch & Lomb
  1. CSB-C20-003-A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group, Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Stage 2 and 3 Neurotrophic Keratitis Subjects
  1. Sponsor: Claris Biotherapeutics, Inc.
  1. OPI-NYXRM- -302-MIRA-3 - Randomized, Parallel-Arm, Double-Masked, Placebo-Controlled Study of the

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to

Reverse Pharmacologically Induced Mydriasis in Healthy Subjects Sponsor: Ocuphire Pharma, Inc.

  1. QC-202-A randomized active-controlled multi-site double-masked study to evaluate the safety and tolerability of 2 concentrations of QLS-101 versus timolol maleate Preservative Free (PF) 0.5% ophthalmic solution in subjects with normal tension glaucoma
  1. Sponsor: Qlaris
  1. VT-003-A 6-Month, Multicenter, Double-Masked, Randomized, Vehicle-Controlled Phase 3 Safety and Efficacy Study with an Open-Label, 6-Month Safety Extension of BRIMOCHOL™ (Carbachol /Brimonidine Tartrate Fixed-Dose Combination) Topical Ophthalmic Solution vs. Vehicle in Subjects with Emmetropic Phakic and Pseudophakic Presbyopia
  1. Sponsor: Visus Therapeutics, Inc
  1. LAL CSP-029-RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study
  1. Sponsor: RxSight
  1. HSP-VF-21-001-Evaluating reproducibility and repeatability for re:I 24-2 Heru visual field tests
  1. Sponsor: Heru, Inc
  1. PHY1903 FineVision-Clinical Investigation of the Safety and Effectiveness of FINEVISION HP Trifocal IOL
  1.  Sponsor: BVI (Beaver-Visitec International, Inc)
  1.  A Randomized, Double-Masked, Controlled, Single Site Investigator Initiated, Exploratory Study of the Midazolam/Ketamine Melt vs Ketamine Melt alone vs Midazolam Melt alone in subjects undergoing intraocular surgery. (MAKER STUDY-IIT)
  1. Sponsor: Vance Thompson Vision
  1. In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery (PREPARE Study-IIT)
  1. Sponsor: Vance Thompson Vision
  1. The Vision-2 Study-A Multi-Center, Double-Masked, Placebo-Controlled Phase 3 Study of The Safety and Efficacy of 2% Pilocarpine Ophthalmic Spray Administered with the Optejet Microdose Dispenser for Temporary Improvement of Near Vision in Adults with Presbyopia.
  1. Sponsor: Eyenovia, Inc.
  1. B&L 906 A Study to Investigate the Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism
  1. Sponsor: Bausch & Lomb, Incorporated
  2. My Role: Sub-Investigator
  1. Clinical Trial to Investigate the Safety and Effectiveness of a Hydrophilic Multifoca Intraocular Lens RayOne Galaxy RAO605G in Comparison with a Monofocal Intraocular Lens (RAO600C) (WR-2021-US-01)
  1. Sponsor: Rayner Intraocular Lenses Limited
  1. Clinical Investigation of the Safety and Effectiveness of Monofocal PODEYE TORIC Intraocular Lens (IOL)  (PodEye PHY2303)
  1. Sponsor: : Beaver-Visitec International, Inc
  1. A multi-center, prospective, randomized, controlled clinical trial to demonstrate the safety and effectiveness of the full visual range AT ELANA 841P posterior chamber intraocular lens for correction of aphakia following cataract removal
  1. Sponsor: Carl Zeiss Meditec USA, Inc
  1. A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo® on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy (B&L936)
  1. Sponsor: Bausch & Lomb Inc
  1. A Phase 3, Multi-center, Randomized, Double-masked, Placebo/Sham-controlled Study to Evaluate the Safety and Efficacy of Oxygen Enriched, Non-invasive Epithelium-on Corneal Collagen Cross-linking in Eyes with Keratoconus  (GLK-202-02)
  1. Sponsor: Glaukos

FINANCIAL DISCLOSURES

Glaukos: Royalty, Consulting, Equity

Alcon: Grant

Sight Sciences: Grant

Greenman Vision: Equity

Balance Ophthalmics: Equity

True North CRO: Equity